Charlie Hospital Semarang Tbk. vs Suparma Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume), while Suparma Tbk. trades at Rp172 (market cap 701.15B, 378K 24h volume). The key difference: Charlie Hospital Semarang Tbk. and Suparma Tbk. are close in size by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 378K). Which is the better fit depends on your goals.
| RSCH | SPMA | |
|---|---|---|
Market Cap | 742B | 701.15B |
Volume | 29.45M | 378K |
Lot | 294.49K | 3.78K |
Turnover | 8.14B | 64.09M |
Average Price | 276.35 | 169.54 |
Value | 8.14B | 64.09M |
Indicative Equilibrium Price | 270 | 171 |
Indicative Equilibrium Volume | 103 | 300 |
Trailing returns across standard periods
Latest headlines on both assets
PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →